Shenzhen, China
ABOUT BGI CO-WIN BGI Co-win is a private equity firm founded by a team of investment professionals in collaboration with BGI Group, one of the world’s leading life science and genomics companies. Founded in 2016, BGI Co-win focuses on Biotech, Biopharma and Medtech. We provide more than just capital. Leveraging our team members’ profound investing experiences, deep understanding of the local economy and policies, as well as resources from our strategic partners including BGI Group and others, we help our portfolio companies realize their strategic and commercial potential through our value-adding services regarding legal, finance managememt, human resources, etc.
12
Total Investments
12
Portfolio Companies
-
Exits
-
Industries
General Information
Company Overview
About 华大共赢 BGI COWIN
Recent Investments (12)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series A | •••••• | Nov 2023 | |
| Series B | •••••• | Jun 2023 | |
| Angel Round | •••••• | Dec 2022 | |
| Seed Round | •••••• | Nov 2022 | |
| Series A | •••••• | Aug 2022 | |
•••• ••••
|
Series B | •••••• | Sep 2021 |
|
•••• ••••
|
Seed Round | •••••• | Jul 2021 |
|
•••• ••••
|
Series E | •••••• | Dec 2020 |
|
•••• ••••
|
Seed Round | •••••• | Aug 2020 |
|
•••• ••••
|
Series B | •••••• | May 2020 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
